Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys’ initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics ...

Cop: Discovery Suspect Had 4 Explosive Devices

Police Chief: James Lee, Shot Dead after Hostage Standoff, Had 2 Propane Tanks and 2 Pipe Bombs, Said He Was "Ready to Die"

Community Calendar

Deadline for calendar items is two weeks in advance of desired publication date. E-mail information on clubs, lectures, community and religious events, reunions and support groups to drock@pioneerlocal.com or fax to (847) 599-6902.

Family Health Premiums Rise 3 Percent to $13,770 in 2010, But Workers' Share Jumps 14 Percent as Firms Shift Cost Burden

About One In Four Covered Workers Now Face Annual Deductibles Of $1,000 Or More, Including Nearly Half Of Those Employed By Small Businesses

Vedero Software and Cirro Energy Services Develop Automated Demand Response Solution for Texas Electricity Market

Innovative Platform Enables Commercial Building Operators to Generate Revenue and Reduce Costs through Emergency and Economic Demand Response Programs.